Details

DSEN Abstract: How safe is intravitreal bevacizumab to treat common causes of blindness? Emerging real-world data - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Mar 11, 2026 · edition #8
Timestamp
2026-03-11T14:09:00.920Z
Language
en
ID
1048003
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview